Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 08:56 am Purchase |
2023-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
Deep Track Capital, LP | 4,063,676 5.530% |
809,544 (+24.88%) |
Filing History |
| 2024-02-14 08:55 am Unchanged |
2023-12-31 | 13G | Silence Therapeutics plc SLN |
Deep Track Capital, LP | 5,854,740 5.430% |
0 (Unchanged) |
Filing History |
| 2024-02-14 08:54 am Purchase |
2023-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Deep Track Capital, LP | 2,992,731 7.100% |
265,125 (+9.72%) |
Filing History |
| 2024-02-14 08:53 am Sale |
2023-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
Deep Track Capital, LP | 2,044,507 6.790% |
-793,311 (-27.95%) |
Filing History |
| 2024-02-14 08:52 am Sale |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Deep Track Capital, LP | 1,793,966 5.220% |
-197,437 (-9.91%) |
Filing History |
| 2024-02-14 08:52 am Purchase |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Deep Track Capital, LP | 5,750,000 9.600% |
2,645,493 (+85.21%) |
Filing History |
| 2024-02-14 08:51 am Purchase |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 2,997,830 6.180% |
280,659 (+10.33%) |
Filing History |
| 2024-02-14 08:50 am Purchase |
2023-12-31 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 18,400,000 9.650% |
6,097,763 (+49.57%) |
Filing History |
| 2024-02-14 08:50 am Sale |
2023-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
Deep Track Capital, LP | 0 0.000% |
-4,259,653 (Position Closed) |
Filing History |
| 2024-02-14 08:49 am Sale |
2023-12-31 | 13G | IVERIC bio, Inc. ISEE |
Deep Track Capital, LP | 0 0.000% |
-7,878,119 (Position Closed) |
Filing History |
| 2024-02-14 08:48 am Sale |
2023-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Deep Track Capital, LP | 0 0.000% |
-3,250,000 (Position Closed) |
Filing History |
| 2024-02-14 08:47 am Sale |
2023-12-31 | 13G | Immunovant, Inc. IMVT |
Deep Track Capital, LP | 1,000,000 0.690% |
-8,710,000 (-89.70%) |
Filing History |
| 2024-02-14 08:47 am Sale |
2023-12-31 | 13G | Immunic, Inc. IMUX |
Deep Track Capital, LP | 0 0.000% |
-4,022,989 (Position Closed) |
Filing History |
| 2024-02-14 08:46 am Sale |
2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
Deep Track Capital, LP | 0 0.000% |
-12,232,267 (Position Closed) |
Filing History |
| 2024-02-14 08:45 am Unchanged |
2023-12-31 | 13G | HilleVax, Inc. HLVX |
Deep Track Capital, LP | 2,900,000 5.990% |
0 (Unchanged) |
Filing History |
| 2024-02-14 08:45 am Sale |
2023-12-31 | 13G | Structure Therapeutics Inc. GPCR |
Deep Track Capital, LP | 900,000 0.660% |
-7,040,346 (-88.67%) |
Filing History |
| 2024-02-14 08:44 am Purchase |
2023-12-31 | 13G | Geron Corporation GERN |
Deep Track Capital, LP | 29,583,449 5.450% |
5,560,566 (+23.15%) |
Filing History |
| 2024-02-14 08:43 am Sale |
2023-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Deep Track Capital, LP | 2,284,372 5.340% |
-372,529 (-14.02%) |
Filing History |
| 2024-02-14 08:43 am Sale |
2023-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX |
Deep Track Capital, LP | 2,537,176 4.000% |
-837,218 (-24.81%) |
Filing History |
| 2024-02-14 08:42 am Sale |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Deep Track Capital, LP | 0 0.000% |
-6,345,790 (Position Closed) |
Filing History |